Table 1.
Cohort Characteristics
| Male/Female | 11/50 |
| Age (range) | 30 (17–51) |
| African American (%) | 26 (43%) |
| Caucasian (%) | 28 (46%) |
| Other Race/Ethnicity (Asian, Hispanic, Middle Eastern) | 7 (11%) |
| SLE Class at Biopsy | |
| 2 | 6 |
| 3 | 9 |
| 4 | 27 |
| 5 | 6 |
| 3+5 | 6 |
| 4+5 | 10 |
| Median Urine Protein to Creatinine Ratio (range) | 2.3 (0.24–16.5) |
| Median Serum Creatinine, mg/dl (range) | 0.93 (0.38–5.98) |
| Median Prednisone Dose at Urine Collection, mg/d (range) | 17.5 (0–60) |
| Median MMF Dose at Urine Collection, g/d (range) | 0 (0–3000) |
| Median AZA Dose at Urine Collection, mg/d (range) | 0 (0–150) |
| Pulse Corticosteroids Given Before Urine Collection (% patients) | 12 (19%) |